I'll have more late tonight, but Merck's most-recent
proxy statement just hit the SEC's EDGAR filing window.
He is -- in my opinion -- worth every penny: he earned it.
More late tonight, after my other professional commitments are completed. UPDATE: On reflection in the bright sunshine of this Spring morning, I'll simply note that Merck slightly over-acheived on all of its targets for 2012 -- so this compensation package is, in the main, appropriate.
No comments:
Post a Comment